
#IBD specialist and GI MD, staying on top of the diagnostics and treatments while being a resource for patients & providers. 🏳️🌈
San Diego, CA
Joined March 2016
- Tweets883
- Following550
- Followers882
- Likes2.5K
Suresh Pola MD retweeted
Join our world-class team @ClevelandClinic's Digestive Disease Institute @CleClinicMD. We are recruiting GI Hospitalists, General GIs, Transplant Hepatologists and more. Competitive compensation and flexible schedules. Link below to apply.
practicematch.com/physicians…
Suresh Pola MD retweeted
Women with IBD are at increased risk of pre-eclampsia and should start low dose Asa around week 12 gestation. No increased risk of flare with use in pregnancy. Thank you for highlighting @JPAchkarMD
IBD Plenary session at #ACG2023. @UmaMahadevanIBD presenting results on low dose aspirin in pregnancy- no increased risk of IBD flares with aspirin use. Reassuring information. @MRegueiroMD @KatieFalloonMD @IBD_Afzali @DCharabaty @EdwardLoftus2 @shannonchangmd @ibdtweets @IBDMD
Suresh Pola MD retweeted
FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company investor.lilly.com/news-rele…
Suresh Pola MD retweeted
Presidential Plenary Session at #ACG2023- @MRegueiroMD showing results that IBD patients treated with biologics or oral small molecules do not have an increased risk of MACE or VTE events. In fact those on biologics had a lower risk of such events. @MoAlkhayyat @KAlsabb
Suresh Pola MD retweeted
Biologics in pregnancy overall are low risk and data across studies and drugs are consistent. We continue throughout pregnancy and lactation.
Safety of VDZ &UST in pregnancy from #PIANO. Reassuring data from @RishikaChughMD @MLongMD @drdawnbeaulieu @UmaMahadevanIBD journals.lww.com/ajg/abstrac…
Suresh Pola MD retweeted
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab cghjournal.org/article/S1542… @AndresYarur @doc_ibd @ibddocmaria @P_DeepakIBDMD @BeniwalPatelMD @AGA_CGH
Suresh Pola MD retweeted
Multicenter Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease - PubMed @RishikaChughMD @ManuelBragaMD @GuiRamosMD @UmaMahadevanIBD @SunandaKaneMD @Y_ECCO_IBD pubmed.ncbi.nlm.nih.gov/3627…
Suresh Pola MD retweeted
Replying to @charlie_lees @predicct
A few simple questions - which don’t need to take long
How are you?
How is your sleep?
Your energy?
Your mood?
Tell me a little about your diet?
Anything you are avoiding?
Is there anything you can’t do because of your IBD?
Any issues with intimacy?
Suresh Pola MD retweeted
Dr. Gautham Reddy @UChicagoGI updating on #PSC today including clinical trials for treatment. Slooowwwww progress(but progress). Too slow though. What are we missing?
Suresh Pola MD retweeted
@IGIBD1 we americans need to catch up with Europeans in doing abdominal ultrasound, esp intestinal u/s for #ibd. Let’s fix that! @AmerGastroAssn
Suresh Pola MD retweeted
Proudly presenting 2nd Ed Crohn’s and Colitis for Dummies. A book written for patients, friends, families and caregivers with updated chapter contents. Many thanks to @ibdgijami as technical editor and gratitude to @IBDMD for writing Foreward #1 New Release in Gastroenterology
Suresh Pola MD retweeted
I made a bet. I lost. But it still paid off. @LeadFromBehind @RMcElhenney @DrLaPook @NYULangone @RMcElhenney
Suresh Pola MD retweeted
Just got my 🙌🏻 on a copy of @MayoClinic @MayoClinicGIHep “Strategies to manage #IBD and take care of your life”👩🏼⚕️🫶🏻💩📚
Excited to read this patient focused 📖 by the incredible @SunandaKaneMD @FarrayeIBD to learn the language of experts🌟
@AmCollegeGastro @CrohnsColitisFn
Suresh Pola MD retweeted
I have been recommending that my patients wait for this rather than get the previously available 4th dose/booster.
nytimes.com/2022/08/31/us/po…
Suresh Pola MD retweeted
Tomorrow, after years of advocacy by Americans working to improve our mental health system, 988 will become our new nationwide number for suicide prevention, mental health and substance use crises. Call or text 988 for a trained counselor who can provide support. #988Lifeline
Suresh Pola MD retweeted
Dr. @IBDUpdates addressing a very important but little discussed topic on mental health
🔹Please have a low threshold to seek help
🔹Mental health disorders are treatable 🙏🏽🙏🏽
🔹You're not alone here
Very powerful, thank you Dr. Pola!
#SouthAsianIBD #Pride2022
Suresh Pola MD retweeted
Kicking off #GayPride #SouthAsianIBD style! On Sun, Jun 26, clinicians & patients are invited for a timely FB LIVE on #LGBTQIA Intersectionality in #IBD 🏳️🌈🏳️⚧️
@fitwitmd will be hosting @IBDUpdates @GI_and_BowtieMD @Dishdashfood & #MuratKavlak
Join us on facebook.com/SouthAsianIBD/!
Suresh Pola MD retweeted
STOP-IT. Investigator-led multi-centre trial.
Stopping IFX in CD patients with deep remission results in half having a clinical relapse by 48 weeks (no relapse in pts who continued IFX). Minor benefit in continuing immunosuppressants.
evidence.nejm.org/doi/full/1…
Suresh Pola MD retweeted
In the @AmerGastroAssn Postgraduate Course today I made the case that every person with #IBD should have a disease monitoring strategy based on the phase of their management. Monitoring is the “yin” to the treat-to-target “yang”.
#DDW2022
Suresh Pola MD retweeted
#ECCO2022 Anti TNF still winning 🏆 in CD
CD ulcers > 5mm in terminal ileum: Efficacy IFX>ADA> UST>VEDO
CD ulcers > 5 mm in colon: Efficacy IFX>ADA>VEDO>UST
(No statistical difference between VEDO and UST)
































